Hindman Andrew A.
SEC CIK 1607965 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | SVP, CFO | 384.7K | — | $716.3K | 9 | 2021-08-20 | 2022-11-20 |
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
Hindman Andrew A. made no open-market trades at TBPH in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-22 | 2022-11-18 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | S - Sale | $11.02 | -65.0K | 409.8K | -14% | -$716.3K | |
| 2022-11-22 | 2022-11-20 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $10.85 | -25.1K | 384.7K | -6% | -$271.9K | |
| 2022-08-23 | 2022-08-19 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $9.34 | -25.7K | 473.5K | -5% | -$239.8K | |
| 2022-07-27 | 2022-07-25 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | A - Grant | $0.00 | +20.0K | 499.2K | +4% | $0 | |
| 2022-05-24 | 2022-05-20 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $8.74 | -3,365 | 479.2K | -0.7% | -$29.4K | |
| 2022-02-23 | 2022-02-18 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $9.61 | -26.0K | 481.3K | -5% | -$249.6K | |
| 2021-12-06 | 2021-12-02 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | A - Grant | $0.00 | +340.0K | 507.3K | +203% | $0 | |
| 2021-11-23 | 2021-11-19 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $8.36 | -1,350 | 167.3K | -0.8% | -$11.3K | |
| 2021-08-24 | 2021-08-20 | TBPH | Theravance Biopharma, Inc. | Hindman Andrew A. | SVP, CFO | F - Tax | $14.05 | -17.5K | 167.4K | -9% | -$245.4K |
Purchase Sale Sale after option exercise All abbreviations